Literature DB >> 22282008

[Laryngeal carcinoma: epidemiology, risk factors and survival].

M Pantel1, O Guntinas-Lichius.   

Abstract

Laryngeal cancer is one of the most frequent types of head and neck cancer. The incidence is decreasing for men but still increasing for women. The incidence in Germany is about 5-7/100,000 persons/year for men and 0.6-0.8/100,000 persons/year for women. Due to the increased life expectancy, the average age of patients diagnosed with laryngeal cancer is increasing. Nevertheless, adequately prepared older patients treated by standard protocols can have the same survival and complication rates as younger patients. Tobacco and alcohol are still the primary risk factors responsible for disease in at least 80% of the patients. Despite the many new diagnostic tools, still more than half of the patients are diagnosed at an advanced tumor stage. Survival rates have not improved significantly in the last 10 years in Germany, and the average 5-year overall survival rate is about 60%. However, a decrease in the survival rate, as observed in the USA, cannot be confirmed for Germany.

Entities:  

Mesh:

Year:  2012        PMID: 22282008     DOI: 10.1007/s00106-011-2423-8

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  65 in total

1.  Impact of surgeon and hospital volume on short-term outcomes and cost of laryngeal cancer surgical care.

Authors:  Christine G Gourin; Arlene A Forastiere; Giuseppe Sanguineti; Wayne M Koch; Shanthi Marur; Robert E Bristow
Journal:  Laryngoscope       Date:  2011-01       Impact factor: 3.325

2.  Malignant transformation of recurrent respiratory papillomatosis associated with integrated human papillomavirus type 11 DNA and mutation of p53.

Authors:  P L Rady; V J Schnadig; R L Weiss; T K Hughes; S K Tyring
Journal:  Laryngoscope       Date:  1998-05       Impact factor: 3.325

3.  An examination of male and female odds ratios by BMI, cigarette smoking, and alcohol consumption for cancers of the oral cavity, pharynx, and larynx in pooled data from 15 case-control studies.

Authors:  Jay H Lubin; Joshua Muscat; Mia M Gaudet; Andrew F Olshan; Maria Paula Curado; Luigino Dal Maso; Victor Wünsch-Filho; Erich M Sturgis; Neonilia Szeszenia-Dabrowska; Xavier Castellsague; Zuo-Feng Zhang; Elaine Smith; Leticia Fernandez; Elena Matos; Silvia Franceschi; Eleonora Fabianova; Peter Rudnai; Mark P Purdue; Dana Mates; Qingyi Wei; Rolando Herrero; Karl Kelsey; Hal Morgenstern; Oxana Shangina; Sergio Koifman; Jolanta Lissowska; Fabio Levi; Alexander W Daudt; Jose Eluf Neto; Chu Chen; Philip Lazarus; Deborah M Winn; Stephen M Schwartz; Paolo Boffetta; Paul Brennan; Ana Menezes; Carlo La Vecchia; Michael McClean; Renato Talamini; Thangarajan Rajkumar; Richard B Hayes; Mia Hashibe
Journal:  Cancer Causes Control       Date:  2011-07-09       Impact factor: 2.506

4.  Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx, and esophagus in northern Italy.

Authors:  S Franceschi; R Talamini; S Barra; A E Barón; E Negri; E Bidoli; D Serraino; C La Vecchia
Journal:  Cancer Res       Date:  1990-10-15       Impact factor: 12.701

5.  EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary.

Authors:  Milena Sant; Claudia Allemani; Mariano Santaquilani; Arnold Knijn; Francesca Marchesi; Riccardo Capocaccia
Journal:  Eur J Cancer       Date:  2009-01-24       Impact factor: 9.162

6.  Active and involuntary tobacco smoking and upper aerodigestive tract cancer risks in a multicenter case-control study.

Authors:  Yuan-Chin Amy Lee; Manuela Marron; Simone Benhamou; Christine Bouchardy; Wolfgang Ahrens; Hermann Pohlabeln; Pagona Lagiou; Dimitrios Trichopoulos; Antonio Agudo; Xavier Castellsague; Vladimir Bencko; Ivana Holcatova; Kristina Kjaerheim; Franco Merletti; Lorenzo Richiardi; Gary J Macfarlane; Tatiana V Macfarlane; Renato Talamini; Luigi Barzan; Cristina Canova; Lorenzo Simonato; David I Conway; Patricia A McKinney; Raymond J Lowry; Linda Sneddon; Ariana Znaor; Claire M Healy; Bernard E McCartan; Paul Brennan; Mia Hashibe
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

7.  National Cancer Database report on cancer of the head and neck: 10-year update.

Authors:  Jay S Cooper; Kim Porter; Katherine Mallin; Henry T Hoffman; Randal S Weber; Kian K Ang; E Greer Gay; Corey J Langer
Journal:  Head Neck       Date:  2009-06       Impact factor: 3.147

8.  Second primary tumors following tobacco dependence treatments among head and neck cancer patients.

Authors:  Yolanda I Garces; Darrell R Schroeder; Liza M Nirelli; Gary A Croghan; Ivana T Croghan; Robert L Foote; Richard D Hurt
Journal:  Am J Clin Oncol       Date:  2007-10       Impact factor: 2.339

9.  Tobacco smoking and the risk of upper aero-digestive tract cancers: A reanalysis of case-control studies using spline models.

Authors:  Jerry Polesel; Renato Talamini; Carlo La Vecchia; Fabio Levi; Luigi Barzan; Diego Serraino; Silvia Franceschi; Luigino Dal Maso
Journal:  Int J Cancer       Date:  2008-05-15       Impact factor: 7.396

10.  Alcoholism: independent predictor of survival in patients with head and neck cancer.

Authors:  F W Deleyiannis; D B Thomas; T L Vaughan; S Davis
Journal:  J Natl Cancer Inst       Date:  1996-04-17       Impact factor: 13.506

View more
  13 in total

1.  Small molecules in combination with conventional chemotherapeutic drugs: Light at the end of the tunnel?

Authors:  Martin Leinung; Clemens Cuny; Marc Diensthuber; Timo Stöver; Jens Wagenblast
Journal:  Oncol Lett       Date:  2012-08-28       Impact factor: 2.967

2.  Epidemiology of laryngeal carcinoma in Germany, 1998-2011.

Authors:  Maximilian Peller; Alexander Katalinic; Barbara Wollenberg; Ingo U Teudt; Jens-E Meyer
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-02-15       Impact factor: 2.503

3.  [Laryngectomy-still state of the art?]

Authors:  J M Vahl; P J Schuler; J Greve; S Laban; A Knopf; T K Hoffmann
Journal:  HNO       Date:  2019-12       Impact factor: 1.284

4.  [Swallowing disorders after partial laryngectomy. Prevalence and predictors].

Authors:  A Meyer; A Dietz; D Wollbrück; J Oeken; H Danker; E F Meister; A Sandner; W Völkel; E Brähler; S Singer
Journal:  HNO       Date:  2012-10       Impact factor: 1.284

5.  Long-term trends in gender, T-stage, subsite and treatment for laryngeal cancer at a single center.

Authors:  Jesper Brandstorp-Boesen; Ragnhild Sørum Falk; Morten Boysen; Kjell Brøndbo
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-05-29       Impact factor: 2.503

6.  Lymph node ratio is of limited value for the decision-making process in the treatment of patients with laryngeal cancer.

Authors:  Julian Künzel; Konstantinos Mantsopoulos; Georgios Psychogios; Abbas Agaimy; Philipp Grundtner; Michael Koch; Heinrich Iro
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-03-19       Impact factor: 2.503

7.  Probe-based confocal laser endomicroscopy in detecting malignant lesions of vocal folds.

Authors:  M Goncalves; M Aubreville; S K Mueller; M Sievert; A Maier; H Iro; C Bohr
Journal:  Acta Otorhinolaryngol Ital       Date:  2019-01-31       Impact factor: 2.124

8.  Retrospective analysis of prognostic factors in 205 patients with laryngeal squamous cell carcinoma who underwent surgical treatment.

Authors:  Si-Yi Zhang; Zhong-Ming Lu; Xiao-Ning Luo; Liang-Si Chen; Ping-Jiang Ge; Xin-Han Song; Shao-Hua Chen; Yi-Long Wu
Journal:  PLoS One       Date:  2013-04-04       Impact factor: 3.240

9.  Subpopulations of natural killer-T-like cells before and after surgical treatment of laryngeal cancer.

Authors:  Janusz Klatka; Ewelina Grywalska; Anna Hymos; Ewelina Krasowska; Michał Mielnik; Dorota Siwicka-Gieroba; Justyna Markowicz; Piotr Trojanowski; Witold Olszański; Jacek Roliński
Journal:  Cent Eur J Immunol       Date:  2017-10-30       Impact factor: 2.085

10.  Association of Smoking and XPG, CYP1A1, OGG1, ERCC5, ERCC1, MMP2, and MMP9 Gene Polymorphisms with the early detection and occurrence of Laryngeal Squamous Carcinoma.

Authors:  Yi Zhu; Luo Guo; ShengZi Wang; Qun Yu; JianXiong Lu
Journal:  J Cancer       Date:  2018-02-28       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.